FindTrial
Sign In

An observational study on the sensitivity of patients with obstructive sleep apnea to remifentanil

An observational study on the sensitivity of patients with obstructive sleep apnea to remifentanil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054302
Enrollment
Unknown
Registered
2021-12-13
Start date
2021-12-30
Completion date
Unknown
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea syndrome

Interventions

obstructive sleep apnea group:target-controlled infusion remifentanil
control group:target-controlled infusion remifentanil

Sponsors

The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male patients with ENT under elective general anesthesia; 2. American Society of Anesthesiologists (ASA) grades I to II; 3. Aged 18 to 65 years; 4. Junior high school education level or above. 5. Body mass index 18-30kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Mental illness; 2. Obvious damage to organs such as heart, lung, liver and kidney; 3. Infection and fever; 4. Hearing and language comprehension impairment; 5. History of alcoholism, chronic pain, and long-term use of analgesic drugs.

Design outcomes

Primary

MeasureTime frame
pupil size;pain threshold;—

Countries

China

Contacts

Public ContactMei Xi

The Third Xiangya Hospital of Central South University

705406446@qq.com+86 15873162864

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026